Szymon Drygala

5PUBLICATIONS
18CO-AUTHORS
Behavioural epidemiologyInfant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 22, 2024
Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II).

Ariel Liebert, Maria Kłopocka, Agata Michalak

|Feb 16, 2024
Facilitated subcutaneous immunoglobulin treatment patterns in pediatric patients with primary immunodeficiency diseases.

Monika Mach-Tomalska, Anna Pituch-Noworolska, Ewa Bień

|Jul 25, 2023
Subcutaneous immunoglobulin 20% (Ig20Gly) treatment regimens in pediatric patients with primary immunodeficiencies - real-world data from the IG TATRY study.

Edyta Heropolitańska-Pliszka, Małgorzata Pac, Barbara Pietrucha

|Feb 23, 2023
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study.

Piotr Eder, Maria Kłopocka, Halina Cichoż-Lach

|Jan 02, 2023
In Vitro Assays for Diagnosis of Drug-Induced Nonsevere Exanthemas: A Systematic Review and Meta-Analysis.

Szymon Drygala, Elzbieta Rdzanek, Grzegorz Porebski

Pageof 1

Frequent Collaborators

2 joint publications

Anna Pituch-Noworolska

2 joint publications

Magdalena Malanowska

2 joint publications

Ewa Bień

2 joint publications

Halina Cichoż-Lach